Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.
Hum Pathol. 2013 Oct;44(10):2220-6. doi: 10.1016/j.humpath.2013.05.004. Epub 2013 Jul 12.
Testicular germ cell tumors (GCTs) commonly metastasize to the retroperitoneal lymph nodes (RPLNs). We evaluated 100 cases of RPLN dissection specimens with viable GCTs after chemotherapy and compared them with their corresponding orchiectomy specimens. The mean age of patients was 28 years (range, 15-58 years). The testicular tumors consisted of mixed GCT (n = 72), teratoma (n = 18), seminoma (n = 4), embryonal carcinoma (n = 3), yolk sac tumor (n = 1), and no viable tumor (n = 2). Somatic malignant components were found in 5 cases. The metastatic tumors in the RPLNs consisted of only teratoma (n = 77) and non-teratomatous GCT (n = 23). Twenty-one patients had only teratoma in the RPLNs but not in the testis, and 10 patients had metastatic non-teratomatous GCT components that were not observed in the testis. Six patients had somatic malignant components in the RPLNs, but only one of them had such a component in the testis. Overall, 13 patients died of disease in a mean of 42 months, and the patients with only teratoma in the RPLNs had a lower mortality rate (9%) than those with non-teratomatous components (26%) (P = .044). One patient with somatic components in the primary GCT and 3 patients with somatic components in the metastases died of disease. Our study demonstrates that there is frequent discordance of histologic composition between primary and metastatic testicular GCTs. Teratoma is the most common component in treated GCTs and is usually associated with a more favorable clinical outcome than non-teratomatous GCTs. The presence of somatic components in the RPLNs metastasis indicates a poor prognosis.
睾丸生殖细胞肿瘤(GCT)通常转移至腹膜后淋巴结(RPLN)。我们评估了 100 例化疗后有存活 GCT 的 RPLN 解剖标本,并将其与相应的睾丸切除术标本进行比较。患者的平均年龄为 28 岁(范围 15-58 岁)。睾丸肿瘤包括混合 GCT(n=72)、畸胎瘤(n=18)、精原细胞瘤(n=4)、胚胎癌(n=3)、卵黄囊瘤(n=1)和无存活肿瘤(n=2)。在 5 例中发现了体细胞恶性成分。RPLN 中的转移性肿瘤仅由畸胎瘤(n=77)和非畸胎瘤 GCT(n=23)组成。21 例患者仅在 RPLN 中有畸胎瘤而在睾丸中没有,10 例患者有转移性非畸胎瘤 GCT 成分而在睾丸中没有观察到。6 例患者在 RPLN 中有体细胞恶性成分,但只有 1 例在睾丸中有这种成分。总体而言,13 例患者在平均 42 个月后死于疾病,而仅在 RPLN 中有畸胎瘤的患者死亡率(9%)低于有非畸胎瘤成分的患者(26%)(P=.044)。1 例原发性 GCT 中有体细胞成分的患者和 3 例转移性肿瘤中有体细胞成分的患者死于疾病。我们的研究表明,原发性和转移性睾丸 GCT 的组织学组成经常存在不一致。畸胎瘤是治疗后 GCT 中最常见的成分,通常与比非畸胎瘤 GCT 更好的临床结果相关。RPLN 转移中存在体细胞成分表明预后不良。